Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Similar documents
Research on Primary Progressive Aphasia: What It Is Teaching Us About Brain Function and Progression

Form D1: Clinician Diagnosis

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Sandra Weintraub, PhD Clinical Core Leader and Professor

! slow, progressive, permanent loss of neurologic function.

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

FTD/PPA Caregiver Education Conference March 11, 2011

I do not have any disclosures

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

Presenter Disclosure Information. I have no financial relationships to disclose:

FTD basics! Etienne de Villers-Sidani, MD!

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

2016 Programs & Information

genetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Confronting the Clinical Challenges of Frontotemporal Dementia

Cognitive Ability (Decline) & Social Isolation

Form A3: Subject Family History

CNADC. S. Weintraub, CNADC, Northwestern FSM, 2011 DO NOT COPY OR DISTRIBUTE WITHOUT AUTHORʼS PERMISSION

Frontotemporal dementia:

The ABCs of Dementia Diagnosis

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Prof Tim Anderson. Neurologist University of Otago Christchurch

Caring Sheet #11: Alzheimer s Disease:

Non Alzheimer Dementias

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Piano playing skills in a patient with frontotemporal dementia: A longitudinal case study

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

What is. frontotemporal. address? dementia?

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

Dr Fiona Kumfor University of Sydney

Mild Cognitive Impairment (MCI)

What is frontotemporal dementia?

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Clinical Genetics & Dementia

Paper Title Theme Presentation Type Poster Presentatio n Day

Evaluations. Alzheimer s Disease A Public Health Response. Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors:

Biomarkers: Translating Research into Clinical Practice

8/24/18. Dementia. Risk of Dementia Following Traumatic Brain Injury: A Review of the Literature. Media Presence. Media Presence

Imaging of Alzheimer s Disease: State of the Art

10 Signs of AD. Sources for Information and Support. Inside this issue: National Centralized Repository. Alzheimer s Disease and Related Dementias

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Dementia Past, Present and Future

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter

Vascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center

review of existing studies on ASL in dementia Marion Smits, MD PhD

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

UDS version 3 Summary of major changes to UDS form packets

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

UCSF Memory and Aging Center 2016

What is primary progressive aphasia?

Dementia. Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

Memory Loss, Dementia and Alzheimer's Disease: The Basics

The Person: Dementia Basics

ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide

PROJECTION: Worlds dementia population is expected to triple by 2050

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018

Contents. Introduction. Introduction 03

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Behavioural variant frontotemporal dementia with dominant gait disturbances case report

Recent publications using the NACC Database. Lilah Besser

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

Clinical phenotypes in autopsy-confirmed Pick disease

Assessing and Managing the Patient with Cognitive Decline

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

CNADCNEWS. Researchers have long chronicled. fall 2012 STUDYING THE SECRETS OF SUPERAGER BRAINS. Northwestern University Feinberg School of Medicine

The Carroll A. Campbell, Jr. Neuropathology Laboratory: A Tool for Dementia Discovery in South Carolina

Part 2: Early detection, assessment and treatment in relation to the new guidelines. Christopher Patterson McMaster University

Frontotemporal Degeneration

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders. National Institute on Aging National Institutes of Health

Pamela S. Klonoff, PhD Clinical Director Center for Transitional Neuro-Rehabilitation Barrow Neurological Institute, Phoenix, Arizona

FTD: Improving Outcomes & Outreach

Differential Diagnosis

The 90+ Study Studies of The Oldest-Old

LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders

Neuro degenerative PET image from FDG, amyloid to Tau

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Maximizing Functional Outcomes for Patients With Dementia: Best Buy FACULTY

4/11/2017. The impact of Alzheimer s disease. Typical changes. The impact of Alzheimer s disease. Problematic changes. Problematic changes

NIH Public Access Author Manuscript Neurology. Author manuscript; available in PMC 2009 September 2.

Alzheimer s disease is an

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

Transcription:

Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois

Dementia: a condition caused by a disease Affects all thinking abilities, behavior, personality Gradual change from a prior level Progressive decline Customary activities of daily living, work and social relations are impaired Shortens one s life expectancy S. Weintraub, CNADC, Northwestern FSM, 2009

DEMENTIA IS A SYMPTOM OF DISEASE IN THE BRAIN LIKE FEVER IS A SYMPTOM OF DISEASE IN THE BODY S. Weintraub, CNADC, Northwestern FSM, 2009

DEMENTIA SYMPTOMS COME IN DIFFERENT FORMS LOSS OF SHORT TERM MEMORY- PrAD LOSS OF LANGUAGE: NAMING, UNDERSTANDING - PPA LOSS OF JUDGMENT, SOCIAL SKILLSbvFTD LOSS OF VISUAL PERCEPTIONprogressive visuospatial dysfunction S. Weintraub, CNADC, Northwestern FSM, 2009

WHAT CAUSES DEMENTIA? DAMAGE TO BRAIN CELLS AND CONNECTIONS MULTIPLE STROKES NEURODEGENERATIVE DISEASES OF THE BRAIN ALZHEIMERʼS DISEASE Amyloid, tau FRONTOTEMPORAL LOBAR DEGENERATION PROTEIN=TAU Pickʼs Disease CBD PSP S. Weintraub, CNADC, Northwestern FSM, 2009 PROTEIN=TDP-43 FTDU-MND NEW PROTEIN?

FTLD PATHOLOGY PRODUCES TWO CLASSES OF DEMENTIA SYMPTOMS LANGUAGE TYPE PRIMARY PROGRESSIVE APHASIA (PPA) Progranulin mutations Young onset (<65) BEHAVIORAL TYPE Behavioral Variant Frontotemporal Dementia (BvFTD) Tau and Progranulin mutations Young onset (<65) S. Weintraub, CNADC, Northwestern FSM, 2009

Behavioral Variant FTD Initial: decline in social/interpersonal conduct; poor judgment and/or loss of initiative; no memory or language loss INITIALLY Loss of typical emotional responses Progresses: to affect other cognitive functions Early neuroimaging: prefrontal cortex Unaware of personality and cognitive changes

Primary Progressive Aphasia= PPA Initial: finding words while speaking; no memory loss; no behavioral change INITIALLY Progresses: other language deficits (understanding conversation, reading, writing) Progresses: to affect other cognitive and behavioral functions Early neuroimaging: language brain regions Affected individuals are aware of illness

DEMENTIA OF ALZHEIMER S DISEASE Short term memory loss; spatial (space) and temporal (time) disorientation DEMENTIAS OF FRONTOTEMPORAL LOBAR DEGENERATION Type 1 Behavioral variant FTD: Deficits in executive functions, social skills, personality Type 2 Primary Progressive Aphasia: Impairments in speaking, understanding, Reading and writing S. Weintraub, CNADC, Northwestern FSM, 2009

PPA bvftd Aphasia Language Disorder Personality Judgment CLINICAL What the doctor diagnoses during life: Symptoms Probable AD Short Term Memory 80% 70% PATHOLOGY What the neuropathologist diagnoses after brain autopsy: Cell Abnormalities FTLD-T FTLD-U 90+% AD Wieneke & Weintraub

Different Types Of Research Observing and measuring behavior Inspecting brain regions on MRI Memory loss vs aphasia vs behavior change Which regions? How do they differ from normal? Inspecting brain tissue Measuring proteins, genes Developing and testing drugs Testing other intervention Based on which proteins and genes are involved What works for management and coping?

Pace is SLOW RESEARCH PROGRESS Breakthroughs come after many years of work and many different laboratories bringing together their findings: 5+ YEARS FOR DRUGS Participation in clinical studies: how the disease affects the person and their loved ones; risk factors for illness Participation in brain imaging studies: find new ways to diagnose the disease Participation in brain donation programs: discover new proteins for drug development

Northwestern New Funding GRANT FOR INTERNATIONAL REGISTRY FOR PPA to Dr. Nancy Johnson IMPPACT: International PPA Consortium SOCIAL SECURITY ADMINISTRATION HEARING ON YOUNG ONSET DEMENTIA- RAISE AWARENESS OF PPA and bvftd (AFTD, AA)

CLINICAL DIAGNOSIS Subtyping: different forms of aphasia can improve prediction of pathology in the brain BRAIN IMAGING STUDIES Cortical Thickness Mapping shows different regions of cell loss depending on the type of language deficit PROTEINS AND GENES Progranulin mutations responsible for PPA in two families What role does TDP-43 play in brain pathology?

UNDERSTANDING SYMPTOMS IN BVFTD (Osher) Emotional signals are processed abnormally in people with bvftd. They cannot interpret negative emotion but have an easier time understanding positive emotion. BANKRUPTCY PROMOTION

PPA Project Funded by the National Institute on Deafness and Communication Disorders (NIDCD) 36 Individuals with PPA recruited in first year (16 above target!) Continuing to recruit and now following up initial participants WHAT WILL THIS TELL US? Different symptoms predict different forms of pathology How does the disease progress in different individuals behaviorally? In the brain?

Future Research at Northwestern TREATMENT TRIALS: Memantine for bvftd What are the best ways we know now to intervene and live with PPA and bvftd? ADEAR Booklet Midwest-Southwest Consortium for FTD Improve diagnostic accuracy and standardize the way in which we make the pathologic diagnosis of diseases that cause bvftd (Bigio) PPA Program years 3-5 How does illness progress and what are early signs that predict different routes of progression?

FROM CELLS.. Neuropathologic features of FTLDs Longitudinal Study Of Language In PPA Electrophysiological Brain Neuropsychiatric Symptoms In bvftd and PPA Neuroimaging of PPA and bvftd Treatment of PPA and bvftd Education and Support for bvftd and PPA S. Weintraub, CNADC, Northwestern FSM, 2009 TO SOCIAL WORK